Segmentation by type isolates the physical and activity‑based configurations of Cs-137 that underpin market dynamics. Sealed sources dominate, subdivided into high‑activity (>1 GBq), medium‑activity (100 MBq–1 GBq), and low‑activity (<100 MBq) categories; high‑activity units are prevalent in medical and industrial settings, driving higher average selling prices, while low‑activity forms serve research and environmental uses, expanding the overall addressable base. Liquid sources—typically CsCl solutions—are confined to calibration labs and niche research, representing a modest share but demanding specialized containment, which elevates cost per curie. Encapsulated sources—glass or ceramic matrices within steel housings—offer enhanced durability for field applications, influencing procurement decisions in radiography and security screening. Additionally, isotopic generators that derive Cs-137 from parent isotopes provide on‑site production capability, a growing sub‑segment responding to supply‑chain resilience concerns. Each type’s distinct regulatory pathway, handling requirement, and end‑use profile contributes incrementally to the total Cs-137 market valuation.